SELO expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.234000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.873000E-01
Normal-vs-Stage2
3.527600E-01
Normal-vs-Stage3
3.131000E-01
Normal-vs-Stage4
1.198220E-01
Stage1-vs-Stage2
6.110000E-01
Stage1-vs-Stage3
3.398600E-01
Stage1-vs-Stage4
9.661800E-02
Stage2-vs-Stage3
3.643400E-01
Stage2-vs-Stage4
8.031900E-02
Stage3-vs-Stage4
5.174600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.286600E-01
Normal-vs-AfricanAmerican
5.275200E-01
Normal-vs-Asian
7.426200E-01
Caucasian-vs-AfricanAmerican
7.308000E-01
Caucasian-vs-Asian
3.964000E-01
AfricanAmerican-vs-Asian
4.428200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.962600E-01
Normal-vs-Female
4.598200E-01
Male-vs-Female
9.559000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.517000E-01
Normal-vs-Age(41-60Yrs)
2.431200E-01
Normal-vs-Age(61-80Yrs)
5.073400E-01
Normal-vs-Age(81-100Yrs)
4.920600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.628800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.388400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.592200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.276000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.684600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.104400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.558600E-01
Normal-vs-Daily Drinker
8.860000E-01
Normal-vs-Weekly Drinker
9.675600E-01
Normal-vs-Occasional Drinker
7.074400E-01
Normal-vs-Social Drinker
2.938400E-01
Non Drinker-vs-Daily Drinker
3.194000E-01
Non Drinker-vs-Weekly Drinker
1.443370E-01
Non Drinker-vs-Occasional Drinker
8.889600E-01
Non Drinker-vs-Social Drinker
4.644800E-01
Daily Drinker-vs-Weekly Drinker
7.770000E-01
Daily Drinker-vs-Occasional Drinker
5.826200E-01
Daily Drinker-vs-Social Drinker
1.860230E-01
Weekly Drinker-vs-Occasional Drinker
4.105600E-01
Weekly Drinker-vs-Social Drinker
4.355600E-02
Occasional Drinker-vs-Social Drinker
5.456400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.501200E-01
Normal-vs-Grade 2
9.454000E-01
Normal-vs-Grade 3
9.069800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.956800E-01
Grade 1-vs-Grade 3
3.358800E-01
Grade 1-vs-Grade 4
9.501200E-01
Grade 2-vs-Grade 3
5.445800E-01
Grade 2-vs-Grade 4
9.454000E-01
Grade 3-vs-Grade 4
9.069800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.989200E-01
Normal-vs-NonDiabetic
5.436600E-01
Diabetic-vs-NonDiabetic
8.602600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.415800E-01
Normal-vs-NoPancreatitis
4.425600E-01
Pancreatitis-vs-NoPancreatitis
2.038600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.739600E-01
Normal-vs-N1
3.335000E-01
N0-vs-N1
4.863000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.062800E-01
Normal-vs-TP53-NonMutant
5.898800E-01
TP53-Mutant-vs-TP53-NonMutant
2.184400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
